Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2012 1
2013 3
2014 1
2015 9
2016 7
2017 7
2018 11
2019 3
2020 4
Text availability
Article attribute
Article type
Publication date

Search Results

43 results
Results by year
Filters applied: . Clear all
Page 1
Fertility results and pregnancy outcomes after conservative treatment of cervical cancer: a systematic review of the literature.
Bentivegna E, Maulard A, Pautier P, Chargari C, Gouy S, Morice P. Bentivegna E, et al. Fertil Steril. 2016 Oct;106(5):1195-1211.e5. doi: 10.1016/j.fertnstert.2016.06.032. Epub 2016 Jul 16. Fertil Steril. 2016. PMID: 27430207 Review.
[Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumors: Guidelines from the French national network dedicated to rare gynaecological cancer].
Rousset-Jablonski C, Selle F, Adda-Herzog E, Planchamp F, Selleret L, Pomel C, Chabbert-Buffet N, Daraï E, Pautier P, Trémollières F, Guyon F, Rouzier R, Laurence V, Chopin N, Faure-Conter C, Bentivegna E, Vacher-Lavenu MC, Lhomme C, Floquet A, Treilleux I, Lecuru F, Gouy S, Kalbacher E, Genestie C, de la Motte Rouge T, Ferron G, Devouassoux-Shisheboran M, Kurtz JE, Namer M, Joly F, Pujade-Lauraine E, Grynberg M, Querleu D, Morice P, Gompel A, Ray-Coquard I. Rousset-Jablonski C, et al. Among authors: bentivegna e. Bull Cancer. 2018 Mar;105(3):299-314. doi: 10.1016/j.bulcan.2017.10.032. Bull Cancer. 2018. PMID: 29397916 French.
Fertility-sparing surgery in epithelial ovarian cancer.
Bentivegna E, Morice P, Uzan C, Gouy S. Bentivegna E, et al. Future Oncol. 2016 Feb;12(3):389-98. doi: 10.2217/fon.15.319. Epub 2016 Jan 15. Future Oncol. 2016. PMID: 26768952 Review.
Clinical utility of SMARCA4 testing by immunohistochemistry in rare ovarian tumours.
Genestie C, Blanc-Durand F, Auguste A, Pautier P, Dunant A, Scoazec JY, Gouy S, Morice P, Bentivegna E, Maulard A, LeFormal A, Devouassoux-Shisheboran M, Leary A. Genestie C, et al. Among authors: bentivegna e. Br J Cancer. 2020 Feb;122(4):564-568. doi: 10.1038/s41416-019-0687-z. Epub 2019 Dec 17. Br J Cancer. 2020. PMID: 31844183
Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumours: guidelines from the French national network dedicated to rare gynaecological cancers.
Rousset-Jablonski C, Selle F, Adda-Herzog E, Planchamp F, Selleret L, Pomel C, Daraï E, Chabbert-Buffet N, Pautier P, Trémollières F, Guyon F, Rouzier R, Laurence V, Chopin N, Faure-Conter C, Bentivegna E, Vacher-Lavenu MC, Lhomme C, Floquet A, Treilleux I, Lecuru F, Gouy S, Kalbacher E, Genestie C, Thibault MR, Ferron G, Devouassoux M, Kurtz JE, Provansal M, Namer M, Joly F, Pujade-Lauraine E, Grynberg M, Querleu D, Morice P, Gompel A, Ray-Coquard I. Rousset-Jablonski C, et al. Among authors: bentivegna e. Eur J Cancer. 2019 Jul;116:35-44. doi: 10.1016/j.ejca.2019.04.018. Epub 2019 Jun 3. Eur J Cancer. 2019. PMID: 31170563
Image-guided adaptive brachytherapy in primary vaginal cancers: A monocentric experience.
Huertas A, Dumas I, Escande A, Rivin Del Campo E, Felefly T, Canova CH, Tailleur A, Gouy S, Bentivegna E, Morice P, Haie-Meder C, Chargari C, Mazeron R. Huertas A, et al. Among authors: bentivegna e. Brachytherapy. 2018 May-Jun;17(3):571-579. doi: 10.1016/j.brachy.2018.01.005. Epub 2018 Feb 6. Brachytherapy. 2018. PMID: 29426746
Dose-volume effects in pathologic lymph nodes in locally advanced cervical cancer.
Bacorro W, Dumas I, Escande A, Gouy S, Bentivegna E, Morice P, Haie-Meder C, Chargari C. Bacorro W, et al. Among authors: bentivegna e. Gynecol Oncol. 2018 Mar;148(3):461-467. doi: 10.1016/j.ygyno.2017.12.028. Epub 2018 Jan 8. Gynecol Oncol. 2018. PMID: 29325690
Sentinel lymph node in endometrial cancer: a review.
Touboul C, Bentivegna E, Uzan C, Gouy S, Pautier P, Lhommé C, Duvillard P, Haie-Meder C, Morice P. Touboul C, et al. Among authors: bentivegna e. Curr Oncol Rep. 2013 Dec;15(6):559-65. doi: 10.1007/s11912-013-0345-1. Curr Oncol Rep. 2013. PMID: 24190831 Review.
Characteristics and Prognosis of Stage I Ovarian Mucinous Tumors According to Expansile or Infiltrative Type.
Gouy S, Saidani M, Maulard A, Bach-Hamba S, Bentivegna E, Leary A, Pautier P, Devouassoux-Shisheboran M, Genestie C, Morice P. Gouy S, et al. Among authors: bentivegna e. Int J Gynecol Cancer. 2018 Mar;28(3):493-499. doi: 10.1097/IGC.0000000000001202. Int J Gynecol Cancer. 2018. PMID: 29466254
43 results
Jump to page
Feedback